A33 CLINICAL STUDIES IN OBSTRUCTIVE LUNG DISEASE: Association Of Platelet Count And Aspirin Use With COPD Morbidity: The Spiromics And COPDgene Cohorts

Elevated platelet count has been associated with increased all-cause mortality in COPD patients while aspirin was associated with reduced mortality and slower progression of subclinical emphysema. Methods: Among participants with COPD (GOLD stage I-IV) from two multi-center observational studies (SP...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 2017-01, Vol.195
Main Authors: Fawzy, A, Putcha, N, Paulin, L M, Aaron, C P, Labaki, W W, Han, M K, Wise, R A, Kanner, R E, Bowler, R, Barr, R G, Hansel, N N
Format: Article
Language:English
Subjects:
Aspirin
Chronic obstructive pulmonary disease
Health risk assessment
Morbidity
Mortality
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title American journal of respiratory and critical care medicine
container_volume 195
creator Fawzy, A
Putcha, N
Paulin, L M
Aaron, C P
Labaki, W W
Han, M K
Wise, R A
Kanner, R E
Bowler, R
Barr, R G
Hansel, N N
description Elevated platelet count has been associated with increased all-cause mortality in COPD patients while aspirin was associated with reduced mortality and slower progression of subclinical emphysema. Methods: Among participants with COPD (GOLD stage I-IV) from two multi-center observational studies (SPIROMICS and COPDGene), reported frequency of acute exacerbations of COPD (AECOPD) in previous year, six-minute-walk distance (6MWD), St. George Respiratory questionnaire (SGRQ), modified Medical Research Council (mMRC) dyspnea scale, and CBC with platelet count were collected at baseline (SPIROMICS) or 5-year visit (COPDGene).
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_1926847808</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1926847808</sourcerecordid><originalsourceid>FETCH-proquest_journals_19268478083</originalsourceid><addsrcrecordid>eNqNzE1OwzAQBWALgUT5ucNIrCM5TUqS7oxjwFJIKuwAuyq0LnEV7BI7C07CdTGIA7CaJ73vzRGaxYtkEaVFho9DxlkSpWnxcorOnNtjHM_zGM_QF0kSoBWvOSUVCNmWnAngNTQ3Qj62VPInBlVb30HJBSOCLYE4Zze689oaaHawGjqvBuWB2sl4IGYbxEGP2kDrFDxr3wNtViU82PFVb7X_XILsFYhg7LveuN_Jj3hTRoUvvR29u0Anu25w6vLvnqOrWybpfXQY7ceknF_v7TSaUK3jYn6dp1mO8-R_6huBG1O9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1926847808</pqid></control><display><type>article</type><title>A33 CLINICAL STUDIES IN OBSTRUCTIVE LUNG DISEASE: Association Of Platelet Count And Aspirin Use With COPD Morbidity: The Spiromics And COPDgene Cohorts</title><source>Freely Accessible Journals</source><source>EZB Electronic Journals Library</source><creator>Fawzy, A ; Putcha, N ; Paulin, L M ; Aaron, C P ; Labaki, W W ; Han, M K ; Wise, R A ; Kanner, R E ; Bowler, R ; Barr, R G ; Hansel, N N</creator><creatorcontrib>Fawzy, A ; Putcha, N ; Paulin, L M ; Aaron, C P ; Labaki, W W ; Han, M K ; Wise, R A ; Kanner, R E ; Bowler, R ; Barr, R G ; Hansel, N N</creatorcontrib><description>Elevated platelet count has been associated with increased all-cause mortality in COPD patients while aspirin was associated with reduced mortality and slower progression of subclinical emphysema. Methods: Among participants with COPD (GOLD stage I-IV) from two multi-center observational studies (SPIROMICS and COPDGene), reported frequency of acute exacerbations of COPD (AECOPD) in previous year, six-minute-walk distance (6MWD), St. George Respiratory questionnaire (SGRQ), modified Medical Research Council (mMRC) dyspnea scale, and CBC with platelet count were collected at baseline (SPIROMICS) or 5-year visit (COPDGene).</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><language>eng</language><publisher>New York: American Thoracic Society</publisher><subject>Aspirin ; Chronic obstructive pulmonary disease ; Health risk assessment ; Morbidity ; Mortality</subject><ispartof>American journal of respiratory and critical care medicine, 2017-01, Vol.195</ispartof><rights>Copyright American Thoracic Society 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Fawzy, A</creatorcontrib><creatorcontrib>Putcha, N</creatorcontrib><creatorcontrib>Paulin, L M</creatorcontrib><creatorcontrib>Aaron, C P</creatorcontrib><creatorcontrib>Labaki, W W</creatorcontrib><creatorcontrib>Han, M K</creatorcontrib><creatorcontrib>Wise, R A</creatorcontrib><creatorcontrib>Kanner, R E</creatorcontrib><creatorcontrib>Bowler, R</creatorcontrib><creatorcontrib>Barr, R G</creatorcontrib><creatorcontrib>Hansel, N N</creatorcontrib><title>A33 CLINICAL STUDIES IN OBSTRUCTIVE LUNG DISEASE: Association Of Platelet Count And Aspirin Use With COPD Morbidity: The Spiromics And COPDgene Cohorts</title><title>American journal of respiratory and critical care medicine</title><description>Elevated platelet count has been associated with increased all-cause mortality in COPD patients while aspirin was associated with reduced mortality and slower progression of subclinical emphysema. Methods: Among participants with COPD (GOLD stage I-IV) from two multi-center observational studies (SPIROMICS and COPDGene), reported frequency of acute exacerbations of COPD (AECOPD) in previous year, six-minute-walk distance (6MWD), St. George Respiratory questionnaire (SGRQ), modified Medical Research Council (mMRC) dyspnea scale, and CBC with platelet count were collected at baseline (SPIROMICS) or 5-year visit (COPDGene).</description><subject>Aspirin</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Health risk assessment</subject><subject>Morbidity</subject><subject>Mortality</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNzE1OwzAQBWALgUT5ucNIrCM5TUqS7oxjwFJIKuwAuyq0LnEV7BI7C07CdTGIA7CaJ73vzRGaxYtkEaVFho9DxlkSpWnxcorOnNtjHM_zGM_QF0kSoBWvOSUVCNmWnAngNTQ3Qj62VPInBlVb30HJBSOCLYE4Zze689oaaHawGjqvBuWB2sl4IGYbxEGP2kDrFDxr3wNtViU82PFVb7X_XILsFYhg7LveuN_Jj3hTRoUvvR29u0Anu25w6vLvnqOrWybpfXQY7ceknF_v7TSaUK3jYn6dp1mO8-R_6huBG1O9</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Fawzy, A</creator><creator>Putcha, N</creator><creator>Paulin, L M</creator><creator>Aaron, C P</creator><creator>Labaki, W W</creator><creator>Han, M K</creator><creator>Wise, R A</creator><creator>Kanner, R E</creator><creator>Bowler, R</creator><creator>Barr, R G</creator><creator>Hansel, N N</creator><general>American Thoracic Society</general><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170101</creationdate><title>A33 CLINICAL STUDIES IN OBSTRUCTIVE LUNG DISEASE: Association Of Platelet Count And Aspirin Use With COPD Morbidity: The Spiromics And COPDgene Cohorts</title><author>Fawzy, A ; Putcha, N ; Paulin, L M ; Aaron, C P ; Labaki, W W ; Han, M K ; Wise, R A ; Kanner, R E ; Bowler, R ; Barr, R G ; Hansel, N N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_19268478083</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aspirin</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Health risk assessment</topic><topic>Morbidity</topic><topic>Mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fawzy, A</creatorcontrib><creatorcontrib>Putcha, N</creatorcontrib><creatorcontrib>Paulin, L M</creatorcontrib><creatorcontrib>Aaron, C P</creatorcontrib><creatorcontrib>Labaki, W W</creatorcontrib><creatorcontrib>Han, M K</creatorcontrib><creatorcontrib>Wise, R A</creatorcontrib><creatorcontrib>Kanner, R E</creatorcontrib><creatorcontrib>Bowler, R</creatorcontrib><creatorcontrib>Barr, R G</creatorcontrib><creatorcontrib>Hansel, N N</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (ProQuest Medical &amp; Health Databases)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fawzy, A</au><au>Putcha, N</au><au>Paulin, L M</au><au>Aaron, C P</au><au>Labaki, W W</au><au>Han, M K</au><au>Wise, R A</au><au>Kanner, R E</au><au>Bowler, R</au><au>Barr, R G</au><au>Hansel, N N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A33 CLINICAL STUDIES IN OBSTRUCTIVE LUNG DISEASE: Association Of Platelet Count And Aspirin Use With COPD Morbidity: The Spiromics And COPDgene Cohorts</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><date>2017-01-01</date><risdate>2017</risdate><volume>195</volume><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Elevated platelet count has been associated with increased all-cause mortality in COPD patients while aspirin was associated with reduced mortality and slower progression of subclinical emphysema. Methods: Among participants with COPD (GOLD stage I-IV) from two multi-center observational studies (SPIROMICS and COPDGene), reported frequency of acute exacerbations of COPD (AECOPD) in previous year, six-minute-walk distance (6MWD), St. George Respiratory questionnaire (SGRQ), modified Medical Research Council (mMRC) dyspnea scale, and CBC with platelet count were collected at baseline (SPIROMICS) or 5-year visit (COPDGene).</abstract><cop>New York</cop><pub>American Thoracic Society</pub></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 2017-01, Vol.195
issn 1073-449X
1535-4970
language eng
recordid cdi_proquest_journals_1926847808
source Freely Accessible Journals; EZB Electronic Journals Library
subjects Aspirin
Chronic obstructive pulmonary disease
Health risk assessment
Morbidity
Mortality
title A33 CLINICAL STUDIES IN OBSTRUCTIVE LUNG DISEASE: Association Of Platelet Count And Aspirin Use With COPD Morbidity: The Spiromics And COPDgene Cohorts
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T08%3A16%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A33%20CLINICAL%20STUDIES%20IN%20OBSTRUCTIVE%20LUNG%20DISEASE:%20Association%20Of%20Platelet%20Count%20And%20Aspirin%20Use%20With%20COPD%20Morbidity:%20The%20Spiromics%20And%20COPDgene%20Cohorts&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Fawzy,%20A&rft.date=2017-01-01&rft.volume=195&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/&rft_dat=%3Cproquest%3E1926847808%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_19268478083%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1926847808&rft_id=info:pmid/&rfr_iscdi=true